Gold miners are back in vogue. It's not surprising, given that the yellow metal has consistently broken all-time highs since Trump re-entered the White House.
However, the recent gold rally is proving to have a much bigger impact on the share prices of gold miners than it has in recent years.
This is because there is now a very healthy margin between the current spot gold price and the all-in-sustaining costs (ASIC) for many gold miners. And this is the case for one UK-listed small-cap miner whose shares have doubled over the past year and are still showing plenty of potential.
Indeed, a rec...
AIM weekly movers: IG Design offloads American business
Blue Star Capital (LON: BLU) says investee company SatoshiPay has a stake in Vortex, which has achieved transaction volumes of $1m since launch in Europe and Brazil. The Vortex platform enables the swapping of stablecoins for local currencies. The share price jumped 133% to 10.5p.
Peptide drug conjugates developer Avacta (LON: AVCT) has appointed David Bryant and Zeus founder Richard Hughes as non-executive directors. Yesterday, Avacta reported delays in its audit and results for 2024 have delayed to 4 June. The share price improved 38.2% to 3.2p.
IG Design (LON: IGR) has sold its American division to a company set up by Hilco Capital. The upfront payment is a nominal $1 and 75% of any proceeds from sale or realisation of assets after the disposal, after agreed adjustments. There may be no additional consideration, especially if the business is not sold. Money owed by the American division will be assigned to the buyer for $1. This business had net assets of $245.4m at the end of September 2024, but it has fallen into loss since then. There will be a considerable write-down of this asset value in the 2024-25 accounts. The risk of further losses is avoided. New financing is being arranged. The share price recovered 34.9% to 85p.
Poolbeg Pharma (LON: POLB) has been granted orphan drug designation by the FDA in the US for POLB001 for treating cytokine release syndrome caused by T cell engager bispecific antibodies. This is a side effect of cancer treatments. POLB001 is ready for a phase 2 study. The status provides seven-year exclusivity after US approval, plus tax credits for development spending. This is a $10bn market. There is potential for securing a partner for clinical trials. The share price rose 30.6% to 3.2p.
FALLERS
A surprise trading statement from contract research business hVIVO (LON: HVO) reveals two contracts have been cancelled, including one large human challenge trial, and one has been postponed, triggered by fears about drug pricing in the US. Contracted revenues are still £47m, but Cavendish expects a loss this year. The share price slumped 48.8% to 8.7p.
Diagnostics company Angle (LON: AGL) increased 2024 revenues by 31% to £2.9m, although the product mix and early discounts to pharma customers meant that gross margins declined. The loss was reduced by 29% to £14.2m after cost savings. Net cash was £10.4m at the end of 2024 with £2.3m of tax credits due, of which £1.4m have been received. The cash should last until the first quarter of 2026. There is uncertainty about timing of new deals that will help to further improve revenues. The share price slipped 23.8% to 8p.
Student accommodation and residential property developer Watkin Jones (LON: WJG) reported interims in line with expectations. Revenues fell from £175m to £129m and there was a pre-tax profit of £200,000, down from £3.4m in the corresponding period. Net cash improved to £73.4m. Further forward sales will enable a pre-tax profit of £4.2m for the full year, but timing is not assured. The share price declined 23.6% to 28.3p.
Catenai (LON: CTAI) investee company Alludium is being included in the NVIDIA Inception partnership programme for AI start-ups. This will help Alludium to expand by having access to NVIDIA technology and it will be offered at a preferential price. There will also be networking opportunities. The share price is one-fifth lower at 0.38p, but it is still 68.9% higher than at the start of the year.
AIM movers: Second Unilever deal for Aptamer and hVIVO hit by cancellations
Synthetic binders developer Aptamer (LON: APTA) has signed a second deal with Unilever for the to develop a panel of Optimer binders for an additional biological pathway associated with body odour formation. This is a fee-for-service deal that will be worth a six-figure sum. On-person trials are planned for the previous programme should commence later this year. The share price increased 13.2% to 0.385p, which is the highest since early March.
Coral Products (LON: CRU) non-executive director David Low has bought 25,000 shares at 8.26p each. He owns 1.57% of the plastic products supplier. The share price moved up 12.1% to 0.385p.
Pharmacogenetic testing company Genedrive (LON: GDR) has gained CE certification for its rapid CYP2C19 ID kit genotyping platform under the European In Vitro Diagnostic Regulation 2017/746. This will enable the kit to be sold in EU countries. Genedrive claims that the platform could potentially prevent 3,000 recurrent stroke admissions in the UK. The share price rose 5.66% to 1.4p.
Logistics Development Group (LON: LDG) had net assets of 24.6p/share at the end of March 2025. Following the recent tender offer, the figure has increased to 26.1p/share. The share price improved 1.67% to 15.25p.
FALLERS
A surprise trading statement from contract research business hVIVO (LON: HVO) reveals two contracts have been cancelled, including one large human challenge trial, and one has been postponed, triggered by fears about drug pricing in the US. Contracted revenues are still £47m, but Cavendish expects a loss this year. The share price slumped 44.4% to 9p.
Petro Matad (LON: MATD) says invoices for seven months of oil sales have been processed ready for payment, but there are delays as the Mongolian authorities assess if there any tax implications. This means that the cash will not be received in May as anticipated. Discussions continue with potential partners for Block XX, which will generate funds for its further development. The share price dived 31.2% to 1.6p.
Flow batteries supplier Invinity Energy Services (LON: IES) reported a fall in full year revenues from £22.1m to £5m, but the loss was lower and the increased number of shares in issue meant that the loss per share fell from 14.7p to 5.3p. Net cash is £32m. Revenues should rebound this year, and the loss fall again. Breakeven is possible in 2026 and net cash could still be £7m at the end of 2026. The share price fell 8.82% to 15.5p.
In the first quarter of 2025, Arrow Exploration (LON: AXL) produced 4,100 barrels of oil equivalent/day. Colombia production declined, but Canada more than made up for that. Production should grow further after a second drilling rig arrives in early June. Up to four wells will be drilled. Net cash was $24m at 1 May. Cash generation will contribute to the $50m of capex in 2025. There is a two-year crude pre-payment agreement with an energy company to market the oil in Colombia. The share price declined 2.94% to 16.5p.
FTSE 100 shakes off tariff twist as M&G soars
The FTSE 100 was firmly higher on Friday as investors shrugged off the latest twist in the trade tariff saga and focused on positive stories closer to home.
London’s leading index rose 0.8% on Friday despite a US appeals court blocking a decision to suspend Donald Trump’s ‘Liberation Day’ tariffs – a move that weighed on US indices overnight.
“When it comes to global trade right now the only certainty is uncertainty. Just a day after US courts halted the lion’s share of Trump’s recent tariff increases, judges have temporarily reinstated the new border taxes,” explained Derren Nathan, head of equity research, Hargreaves Lansdown.
The FTSE 100 has diverged from US indices on a number of occasions this week, with London missing out on a Nvidia-inspired rally but showing greater resilience in the face of the latest development in Donald Trump’s trade war.
“A rally on Wall Street ran out of steam overnight and futures markets are pointing to declines later for the main indices. The FTSE 100 managed gains on Friday morning despite the miners trading lower amid the continuing economic turmoil,” according to AJ Bell investment director Russ Mould.
“The usually staid insurance sector burst into life as M&G’s strategic partnership with Japan’s Dai-ichi Life generated excitement. The deal is expected to generate significant business for the company over the next five years.”
M&G was by far the FTSE 100’s best performer on the session following news of their new strategic partnership with gains of over 6%.
“It brings together two highly complementary international businesses with shared growth ambitions who aim to deliver excellent client service and sustainable shareholder returns,” said Andrea Rossi, Group CEO of M&G.
“It will enable us to further capitalise on the significant private market opportunities across Europe and enable even greater access to the Japanese and Asian market where we will benefit from Dai-ichi Life Holdings market-leading expertise.”
Additional support for the FTSE 100 came from other financials that jumped on M&G’s coattails. Beazley, Hiscox and Schroders were all higher by more than 1% at the time of writing.
IAG was the top faller, giving up around 1%, on nothing more than light profit taking.
M&G shares jump on Dai-ichi Life strategic partnership
M&G shares jumped on Friday after the asset manager announced a strategic partnership with Dai-ichi Life, a Japanese life insurance company with 67.5 trillion yen (£345 billion) in total assets.
M&G has forged an ‘ambitious’ strategic alliance with Japan’s Dai-ichi Life Holdings that will accelerate its European private markets expansion whilst opening doors to lucrative Asian markets.
The partnership positions M&G as Dai-ichi Life HD’s preferred asset management partner in Europe and is expected to generate at least $6 billion in new business flows for the British firm over the next five years. Of this, at least $3 billion will flow into M&G’s market-leading high-alpha strategies across public and private markets.
The deal underscores M&G’s international growth strategy, providing access to Japanese and broader Asian distribution channels through one of the region’s largest insurers.
Dai-ichi Life HD manages substantial assets and the partnership will see M&G support the Japanese firm’s European investment requirements for both its own balance sheet and customer portfolios.
As part of the arrangement, Dai-ichi Life HD will acquire approximately 15% of M&G’s shares through on-market purchases, demonstrating strong confidence in the British firm’s growth prospects. The Japanese insurer will gain board representation and the companies will collaborate on product development and distribution.
Half of the projected $6 billion in new flows will come directly from Dai-ichi Life HD’s balance sheet on an evergreen basis, with the remainder generated through joint development opportunities and product distribution initiatives.
“The strategic partnership with Dai-ichi Life Holdings and the associated c.15% investment is recognition of M&G’s strengths and clear confidence in our leadership, strategy and long-term prospects,” said Andrea Rossi, Group CEO of M&G.
“It brings together two highly complementary international businesses with shared growth ambitions who aim to deliver excellent client service and sustainable shareholder returns.”
The partnership also opens potential for M&G to tap into Japan’s substantial retail market, with Dai-ichi Life HD considering distributing M&G products across Japan and Asia. Both firms will explore co-investment opportunities in new asset management capabilities aligned with their respective growth priorities.
Today’s 6% gain in M&G shares extends their year-to-date rally to 20% and takes the share price to the highest level since early 2024. And it still has a yield of 8%.
Aurora UK Alpha Investment Presentation May 2025
Kartik Kumar, Co-Portfolio Manager of Aurora UK Alpha provides an insight into the company’s research intensive process of selecting underlying holdings.
AIM movers: Blue Star investee company stablecoin platform off to a good start and Tooru completes reverse takeover
Blue Star Capital (LON: BLU) says investee company SatoshiPay has a stake in Vortex, which has achieved transaction volumes of $1m since launch in Europe and Brazil. The Vortex platform enables the swapping of stablecoins for local currencies. The share price jumped 105% to 10.25p.
AI-based services provider to smaller businesses Pri0r1ty Intelligence Group (LON: PR1) has introduced cryptocurrency options to help with online transactions. The company believes that this will increase its customer base. The first Bitcoin payments have been received from customers. The share price doubled from its low to 4.75p
In 2024, CEPS (LON: CEPS) improved revenues by 6% to £31.6m, while pre-tax profit dipped from £1.79m to £1.73m. There was a flat EBITDA contribution from Aford Awards and the slump in Signature Fabrics contribution was offset by higher EBITDA from construction services provider ICA Group. The outlook remains uncertain. The share price is 9.3% higher at 23.5p.
Cyber security company Smarttech247 (LON: S247) has secured renewals and a new contract worth a total of €3.7m. The three renewals are in a range of sectors and the new customer is a US industrial business. Two of the contracts are for three years. This helps to underpin an improvement in full year revenues from €13.2m to €14.2m, rising to €15.3m in the year to July 2026. The share price rose 6.45% to 8.25p.
FALLERS
RiverFort Global Opportunities has completed the acquisition of the healthy snacks businesses of Aquis-quoted S-Ventures (LON: SVEN) and changed its name to Tooru (LON: TOO). Trading in the shares has recommenced at 0.275p, down 14.1%. Further acquisitions are planned. Trading in the shares has recommenced.
Student accommodation and residential property developer Watkin Jones (LON: WJG) reported interims in line with expectations. Revenues fell from £175m to £129m and there was a pre-tax profit of £200,000, down from £3.4m in the corresponding period. Net cash improved to £73.4m. Further forward sales will enable a pre-tax profit of £4.2m for the full year, but timing is not assured. The share price slipped 12.7% to 31.225p.
Oil and gas producer Zephyr Energy (LON: ZPHR) says evaluation of the State 36-2 LNW-CC-R well in the Paradox Basin in Utah confirms that the Cane Creek reservoir is highly productive. There could be an increase in base case resources. First quarter production from the Williston project was 756 barrels of oil equivalent/day net to Zephyr Energy, down from 829 barrels of oil equivalent/day in the fourth quarter of 2024. Production levels should improve. The share price dell 10.2% to 4.15p.
Environmental technology supplier Metir (LON: MET), formerly Microsaic Systems, currently has cash of £151,000 and the company is dependent on timely collection of receivables. The Qatar project payment of £228,000 is not expected until after June, which is later than anticipated because of technical changes. If most of this is not paid in the third quarter, then additional finance may be required. Trading is better than expected. Management believes that Metir can be EBITDA positive in the second half of 2025. The share price dipped 6.9% to 0.675p.
Ex-dividends
Avingtrans (LON: AVG) is paying an interim dividend of 1.9p/share and the share price declined 5p to 410p.
Brave Bison Group (LON: BBSN) is paying a final dividend of 0.02p/share and the share price is unchanged at 2.55p.
Cerillion (LON: CER) is paying an interim dividend of 4.8p/share and the share price increased 30p to 1850p.
H &T (LON: HAT) is paying a final dividend of 11p/share and the share price declined 8p to 638p.
Lords Group Trading (LON: LORD) is paying a final dividend of 0.52p/share and the share price is 1p higher at 37p.
Origin Enterprises (LON: OGN) is paying an interim dividend of 3.15 eurocents/share and the share price is unchanged at 352.5 eurocents.
PetroTal Corp (LON: PTAL) is paying a dividend of 1.5 cents/share and the share price rose 0.25p to 32.25p.
RTC Group (LON: RTC) is paying a final dividend of 5p/share and the share price fell 5p to 100p.
Yu Group (LON: YU.) is paying a final dividend of 41p/share and the share price dipped 20p to 1570p.
FTSE 100 falls despite US tariff ruling and strong Nvidia results
The FTSE 100 fell on Thursday despite a major US court ruling on Trump’s tariffs and strong results from Nvidia sparking a rally in US stocks.
London’s leading index was trading down 0.1% at the time of writing as ex-dividends and disappointing results from Auto Trader weighed.
In contrast, S&P 500 futures surged 1.5% higher on hopes the worst of the negative impact of Trump’s tariffs could be averted, or at the very least, delayed. In a blow for Donald Trump and boon for stocks, a US court ruled that the President acted beyond his powers and block his ‘Liberation Day’ tariffs.
“The US Court of International Trade has generated some hope in the market that the tariff threat might be wiped away with its latest ruling,” said AJ Bell investment director Russ Mould.
“For the court to determine that President Trump didn’t have the authority to impose the ‘Liberation Day’ tariffs is a pretty seismic development.
“That the gains were measured rather than blockbuster reflects a healthy level of scepticism over whether this can truly rein in the Trump administration, which has already launched an appeal against the judgement.”
One would also think the gains in US shares would have had a bigger reaction to the news if Trump had not already rolled back or delayed tariffs on several key trading partners. The S&P 500 has already rallied just shy of 20% since post-tariff lows and is on the verge of a technical bull market.
There has been a similar recovery in the FTSE 100 and the extent of the gains since Trump’s tariff announcment can be attributed to the muted reaction in London’s leading index on Thursday.
Several big hitters, including Severn Trent and National Grid, trading ex-dividend contributed to the weakness on an index level.
Auto Trader was the top faller after the UK’s largest automotive platform announced increased revenues, but warned the strength of the UK second hand car market was reducing demand for their advertising products.
“You would think a buoyant market for used cars would be great news for a platform like Auto Trader but actually if anything it’s been too easy to sell second-hand vehicles of late,” Russ Mould explained.
“Thanks to limited supply and exceptionally strong demand, car tyres are barely touching the forecourt before they are snapped up and this means there is less need for retailers to buy advertising slots from Auto Trader.
“These market dynamics have also made it harder to upsell clients to more expensive packages. This has caused growth to stall and seen the shares go firmly into reverse on the publication of full-year results.”
Auto Trader shares were down 11.5% at the time of writing.
There were surprisingly few FTSE 100 gainers rising more than 1%, given the news breaking from the US. easyjet was the top riser, adding 2.3%.
GenIP breaks into Brazilian market with government agency partnership
Generative AI analytics firm GenIP has continued its global expansion with a fresh partnership with a Brazilian government agency to support innovation in the clean energy space.
The AIM-listed firm has secured an agreement to provide its artificial intelligence-enhanced assessment services to a prominent government research funding body.
The partnership will support a state-backed bioenergy programme aimed at advancing sustainable energy innovation across the country. GenIP’s AI-driven analysis will guide critical decisions regarding the commercial viability of cutting-edge bioenergy technologies.
The Brazilian engagement represents GenIP’s deal in the country, positioning the company to capitalise on the growing demand for technology evaluation services across Latin American markets.
The government agency, which ranks amongst Brazil’s principal funders of scientific and technological research, selected GenIP’s platform to help identify the most promising innovations for potential commercialisation.
GenIP also unveiled its attendance at leading technology transfer and innovation events in the UK and US to support its marketing initiatives.
Today’s announcement builds on recent developments demonstrating GenIP’s global ambitions. In March, GenIP announced a $0.35m contract win with a Saudi Arabian institution, which was closely followed by another contract with a Singapore-based research institute.
“We’re excited to announce GenIP’s expansion into Brazil. This new partnership with a Brazilian government agency reflects the success of our Latin American outreach and highlights the significant opportunity in the region,” said Melissa Cruz, CEO of GenIP.
“Demonstrating GenIP’s ambition to become the global leader in AI-powered technology commercialisation services, our participation in leading tech transfer events this June will allow us to deepen relationships and engage new clients in both the UK and the United States.”

